ADENOID CYSTIC CARCINOMA
Clinical trials for ADENOID CYSTIC CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADENOID CYSTIC CARCINOMA trials appear
Sign up with your email to follow new studies for ADENOID CYSTIC CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New oral cancer drug targets rare salivary gland tumors
Disease control Recruiting nowThis study is testing a new oral medication called REM-422 for people with advanced adenoid cystic carcinoma (ACC), a rare type of cancer often found in salivary glands. The trial aims to find the safest and most effective dose and see if the drug can shrink tumors or slow cancer…
Matched conditions: ADENOID CYSTIC CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Remix Therapeutics • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New pill targets tough cancers in First-Ever human trial
Disease control Recruiting nowThis is the first study in people to test a new oral pill called RGT-61159. It aims to see if the drug is safe and can shrink tumors in adults with advanced adenoid cystic carcinoma or colorectal cancer that has come back or stopped responding to standard treatments. The study wi…
Matched conditions: ADENOID CYSTIC CARCINOMA
Phase: PHASE1 • Sponsor: Rgenta Therapeutics Inc • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Precision chemo blitz aims to spare patients major surgery in rare cancer fight
Disease control Recruiting nowThis study is testing a new, two-step treatment plan for adults with advanced sinonasal adenoid cystic carcinoma, a rare and aggressive cancer. First, all participants receive three sessions of targeted, high-dose chemotherapy delivered directly to the tumor to try to shrink it. …
Matched conditions: ADENOID CYSTIC CARCINOMA
Phase: PHASE2 • Sponsor: Eye & ENT Hospital of Fudan University • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
First human trial launches for promising new cancer treatment
Disease control Recruiting nowThis early-stage study is testing a new drug called XMT-1660 in people with advanced solid tumors that have returned or spread. The main goals are to find a safe dose and see what side effects occur. Researchers will enroll about 319 participants with cancers including triple-neg…
Matched conditions: ADENOID CYSTIC CARCINOMA
Phase: PHASE1 • Sponsor: Mersana Therapeutics • Aim: Disease control
Last updated Apr 02, 2026 14:58 UTC
-
New pill targets tough cancers after other treatments fail
Disease control Recruiting nowThis early-stage study is testing a new oral drug called VMD-928, both by itself and combined with an existing immunotherapy (pembrolizumab). It is for adults with advanced solid tumors or lymphoma that have progressed despite available treatments. The main goals are to find safe…
Matched conditions: ADENOID CYSTIC CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: VM Oncology, LLC • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Targeted radiation blasts early cancer spread in new trial
Disease control Recruiting nowThis study is testing whether using a highly focused type of radiation (SBRT) early on can help control cancer that has spread to a few sites. It will compare this approach to standard care in about 32 patients with adenoid cystic carcinoma. The main goals are to see if it delays…
Matched conditions: ADENOID CYSTIC CARCINOMA
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Experimental drug targets multiple advanced cancers in first human test
Disease control Recruiting nowThis early-stage trial is testing a new cancer drug called NN3201 for the first time in people. The study aims to find a safe dose and see how well the drug works against several advanced solid tumors that have a specific protein called c-Kit. Researchers will enroll 67 adults wi…
Matched conditions: ADENOID CYSTIC CARCINOMA
Phase: PHASE1 • Sponsor: Novelty Nobility, Inc. • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Experimental drug trial offers hope for rare cancer patients
Disease control Recruiting nowThis study is testing whether the drug enfortumab vedotin can help control advanced adenoid cystic carcinoma, a rare cancer that has returned or spread. Researchers will enroll 34 adults whose cancer has progressed despite previous treatments. The trial will measure how well the …
Matched conditions: ADENOID CYSTIC CARCINOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC